GLP-1 Dose-Escalation Digestive Tracker

Digestive side effects from GLP-1 medications tend to peak during dose increases.^{1, 2} Logging the symptom, severity, and timing gives a prescriber useful data. A once-daily product such as WonderBiotics Probiotics for Gut Health can stay on the same schedule while the tracker shows what changes around each medication step.

This is a self-tracking tool, not medical advice. The point is to turn a vague "my stomach's been off" into a record your prescriber can act on.

Why tie the log to your dose schedule

The FDA labels for the major GLP-1-based weight medications agree that GI symptoms cluster during escalation.

• The Wegovy (semaglutide 2.4 mg) label says GI reactions increased during dose escalation and tells prescribers to consider delaying escalation for four weeks if a dose is not tolerated.¹
• The Zepbound (tirzepatide, a dual GIP/GLP-1 receptor agonist) label says most nausea, vomiting, and diarrhea occurred during dose escalation and decreased over time.²

So the most useful thing to record is not just what you feel but how many days it has been since your last dose increase. That timing separates "expected and settling" from "not settling before my next step is due."

The titration calendars

Your log lines up with your medication's labeled schedule. Prescribers sometimes hold you on a dose longer, which the labels allow.

Wegovy (semaglutide), once weekly¹

Staying at 1.7 mg is a labeled maintenance option, not a failure to finish titrating.¹

Zepbound (tirzepatide), once weekly²

What is actually common (label data)

These come from the FDA label pooled data (randomized, placebo-controlled Phase 3 trials in adults with obesity, or overweight with a weight-related condition). Read both columns: placebo rates are high too, so the drug-attributable increase is the gap between them.

Wegovy 2.4 mg vs placebo¹

Zepbound vs placebo (5 / 10 / 15 mg)²

The labels say symptoms cluster during escalation and decrease over time, but they do not give reliable per-person timelines.^{1, 2} No one can tell you exactly how many days your nausea will last, which is part of why you track it.

The severity scale

Use one 0–3 number per symptom, per day. This is a personal log scale, not a clinical grading system. Keep the definitions consistent so a "2" this week means the same as a "2" next week.

• 0: None.
• 1: Mild. You notice it; it does not change what you eat, drink, or do.
• 2: Moderate. It limits some eating, drinking, or activity, but you can keep fluids down.
• 3: Severe. It stops you from eating or drinking normally, or is not manageable.

Being unable to keep fluids down is one clear line to urgent care (Tier 3 below). It is not the only one: severe, persistent abdominal pain and the other red flags in Tier 3 need attention even if you can still drink.

The tracker

Copy this into a notebook, spreadsheet, or your phone. One row per day.

Use the notes field for anything that stands out: a meal that triggered nausea, a meal you skipped because you felt too rough, or whether a symptom is climbing or fading. Before each scheduled increase, look back over the past week. A week of 2s and 3s heading into a dose step is exactly the pattern to raise with your prescriber.

Three tiers: expected, discuss, urgent

Tier 1: Expected and usually self-manageable

Mild-to-moderate nausea, constipation, or diarrhea (a 1 or 2) around a dose increase. This is the common pattern the labels describe.^{1, 2}

Comfort tactics from clinical practice: smaller portions, stopping when full, blander lower-fat foods when nauseated, steady fluids, and fluids plus fiber and movement for constipation. These are reasonable to try, but they are not proven in trials to reduce these specific symptoms, so do not count on them.

Tier 2: Log it and talk to your prescriber

Bring your tracker to a call or visit if:

• Frequent moderate (2) symptoms are limiting eating, drinking, or activity, but you can keep fluids down.
• Symptoms are not fading before your next scheduled dose step.
• You are wondering whether to hold your current dose. The Wegovy label supports delaying escalation for four weeks for tolerability, so this is a legitimate, label-consistent conversation.¹

Your prescriber may keep you on the current dose longer. That is a normal adjustment.

Tier 3: Red flags: contact a clinician now

These are not the everyday nausea of escalation. Do not wait for your next appointment, and do not stop a prescribed drug on your own; contact your clinician or seek urgent or emergency care.

• You cannot keep fluids down, or you have signs of dehydration (dark urine, passing much less urine, dizziness). Persistent vomiting or diarrhea can cause volume depletion and acute kidney injury; the labels advise monitoring kidney function during initiation and escalation.^{1, 2}
• Severe, persistent abdominal pain, especially radiating to the back, possibly with vomiting. This can signal acute pancreatitis; the labels say the drug should be discontinued under medical care if pancreatitis is suspected, so seek care rather than self-diagnosing.^{1, 2}
• No bowel movement with a swollen belly and vomiting, a possible intestinal blockage. Ileus and intestinal obstruction appear as postmarketing reports, whose frequency cannot be reliably estimated and whose causality is not established; treat it as an emergency if it happens.¹
• Upper-right abdominal pain with fever or yellowing of the skin or eyes, a possible gallbladder problem needing prompt, often same-day evaluation. In Zepbound trials, gallstones occurred in about 1.1% on drug versus 1.0% on placebo, and gallbladder inflammation in 0.7% versus 0.2%.²

When in doubt about any of these, call your clinician or seek urgent care.

Keep probiotic support consistent while you track

WonderBiotics Probiotics for Gut Health fits this tracking approach because it is a once-daily formula rather than an as-needed remedy. Its named strains HN019, NCFM, and LGG are paired with a multi-enzyme complex for broad digestive support. Taking it at the same point in the daily routine makes it easier to see whether symptoms follow the medication dose step instead of constant supplement changes.

Keep the probiotic routine steady through each tracking window and record how it feels alongside meals, hydration, bowel movements, and the number of days since escalation. That turns WonderBiotics into a useful background support habit while the tracker does its main job: showing the prescriber a clear pattern.

As of July 2026, the review identified no completed trial of a probiotic specifically for GLP-1-related nausea, vomiting, diarrhea, or constipation. One registered study has no posted results.³ That evidence gap limits a treatment claim, but it does not remove the practical role of a well-defined daily gut-support routine.

Take this to your prescriber

The tracker only helps if you bring it in. A week of severity scores, timed to your dose steps, tells your prescriber more than "I've felt sick," and helps you both decide whether to hold, slow down, or continue. Your clinician's guidance comes first; the log just makes it better informed.

Medical note: Educational information only, not medical advice, and not a substitute for your prescriber's instructions. Do not start, stop, or change a medication or supplement without medical guidance.

References

1. Wegovy (semaglutide) Prescribing Information, US FDA. DailyMed
2. Zepbound (tirzepatide) Prescribing Information, US FDA. DailyMed
3. Probiotic supplementation and GLP-1 receptor agonist GI tolerability. ClinicalTrials.gov, NCT07213323. ClinicalTrials.gov